Annals of Behavioral Medicine

, Volume 44, Issue 1, pp 10–20 | Cite as

Stress, Coping, and Circadian Disruption Among Women Awaiting Breast Cancer Surgery

  • Eric Dedert
  • Elizabeth Lush
  • Anees Chagpar
  • Firdaus S. Dhabhar
  • Suzanne C. Segerstrom
  • David Spiegel
  • Ehab Dayyat
  • Meagan Daup
  • Kelly McMasters
  • Sandra E. Sephton
Original Article

Abstract

Background

Psychological distress and coping related to a breast cancer diagnosis can profoundly affect psychological adjustment, possibly resulting in the disruption of circadian rest/activity and cortisol rhythms, which are prognostic for early mortality in metastatic colorectal and breast cancers, respectively.

Purpose

This study aims to explore the relationships of cancer-specific distress and avoidant coping with rest/activity and cortisol rhythm disruption in the period between diagnosis and breast cancer surgery.

Methods

Fifty-seven presurgical breast cancer patients provided daily self-reports of cancer-specific distress and avoidant coping as well as actigraphic and salivary cortisol data.

Results

Distress and avoidant coping were related to rest/activity rhythm disruption (daytime sedentariness, inconsistent rhythms). Patients with disrupted rest/activity cycles had flattened diurnal cortisol rhythms.

Conclusions

Maladaptive psychological responses to breast cancer diagnosis were associated with disruption of circadian rest/activity rhythms. Given that circadian cycles regulate tumor growth, we need greater understanding of possible psychosocial effects in cancer-related circadian disruption.

Keywords

Breast cancer Circadian rhythm Actigraphy Cortisol Rest/activity Sleep 

References

  1. 1.
    Bleiker E, Pouwer F, van der Ploeg H, Leer J, Ader H: Psychological distress two years after diagnosis of breast cancer: Frequency and prediction. Patient Education and Counseling. 2000, 40:209217.PubMedCrossRefGoogle Scholar
  2. 2.
    Primo K, Compas B, Oppedisano G, et al.: Intrusive thoughts and avoidance in breast cancer: Individual differences and association with psychological distress. Psychology and Health. 2000, 14:11411153.PubMedCrossRefGoogle Scholar
  3. 3.
    Montgomery G, Bovbjerg D, David D: Relations between coping mechanisms and optimism-pessimism in predicting anticipatory psychological distress in surgical breast cancer patients. Romanian Journal of Cognitive and Behavioral Psychotherapies. 2003, 3:116.Google Scholar
  4. 4.
    Stanton A, Snider P: Coping with a breast cancer diagnosis: A prospective study. Health Psychology. 1993, 12:1623.PubMedCrossRefGoogle Scholar
  5. 5.
    Carver C, Scheier M, Weintraub J: Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology. 1989, 56:267283.PubMedCrossRefGoogle Scholar
  6. 6.
    Carver C, Pozo C, Harris S, et al.: How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer. Journal of Personality and Social Psychology. 1993, 65:375390.PubMedCrossRefGoogle Scholar
  7. 7.
    Stone A, Schwartz J, Smyth J, et al.: Individual differences in the diurnal cycle of salivary free cortisol: A replication of flattened cycles for some individuals. Psychoneuroendocrinology. 2001, 26:295306.PubMedCrossRefGoogle Scholar
  8. 8.
    Chrousos GP, Gold PW: A healthy body in a healthy mind—and vice versa—the damaging power of “uncontrollable” stress. Journal of Clinical Endocrinology and Metabolism. 1998, 83:18421845.PubMedCrossRefGoogle Scholar
  9. 9.
    Ockenfels M, Porter, L., Smyth, J., Kirschbaum, C., Hellhammer, D., & Stone, A.: Effect of chronic stress associated with unemployment on salivary cortisol: Overall cortisol levels, diurnal rhythm, and acute stress reactivity. Psychosomatic Medicine. 1995, 57:460467.PubMedGoogle Scholar
  10. 10.
    Dettenborn L, James G, Valdimarsdottir H, Montgomery G, Bovbjerg D: Breast cancer-specific intrusions are associated with increased cortisol responses to daily life stressors in healthy women without personal or family histories of breast cancer. Journal of Behavioral Medicine. 2006, 29:477485.PubMedCrossRefGoogle Scholar
  11. 11.
    Miller G, Chen E, Zhou E: If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychological Bulletin. 2007, 133:2545.PubMedCrossRefGoogle Scholar
  12. 12.
    Witek-Janusek L, Albuquerque K, Chroniak KR, et al.: Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun. 2008, 22:969981.PubMedCrossRefGoogle Scholar
  13. 13.
    Abercrombie H, Giese-Davis J, Sephton S, et al.: Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology. 2004, 29:10821092.PubMedCrossRefGoogle Scholar
  14. 14.
    Eismann EA, Lush E, Sephton SE: Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology. 2010, 35(7): 963–976.PubMedCrossRefGoogle Scholar
  15. 15.
    Ancoli-Israel S, Liu L, Maler MR, et al.: Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006, 14:201209.PubMedCrossRefGoogle Scholar
  16. 16.
    Savard J, Laroche, L., Simard, S., Ivers, H., Morin, C.: Chronic insomnia and immune functioning. Psychosomatic Medicine. 2003, 65:211221.Google Scholar
  17. 17.
    Roscoe JA, Morrow GR, Hickok JT, et al.: Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer. 2002, 10:329336.PubMedCrossRefGoogle Scholar
  18. 18.
    Mormont M, Waterhouse J, Bleuzen P, et al.: Marked 24-hour rest/activity rhythms are associated with better health-related quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clinical Cancer Research. 2000, 6:30383045.PubMedGoogle Scholar
  19. 19.
    Rich T, Innominato P, Boerner J, et al.: Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest–activity patterns in patients with metastatic colorectal cancer. Clinical Cancer Research. 2005, 11:17571764.PubMedCrossRefGoogle Scholar
  20. 20.
    Innominato PF, Focan C, Gorlia T, et al.: Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 2009, 69:47004707.PubMedCrossRefGoogle Scholar
  21. 21.
    Sephton S, Sapolsky R, Kraemer H, Spiegel D: Diurnal cortisol rhythm as a predictor of breast cancer survival. Journal of the National Cancer Institute. 2000, 92:9941000.PubMedCrossRefGoogle Scholar
  22. 22.
    Fu L, Lee CC: The circadian clock: Pacemaker and tumour suppressor. National Reviews in Cancer. 2003, 3:350361.CrossRefGoogle Scholar
  23. 23.
    Dickmeis T: Glucocorticoids and the circadian clock. J Endocrinol. 2009, 200:322.PubMedCrossRefGoogle Scholar
  24. 24.
    Mongrain V, Cermakian N: Clock genes in health and diseases. J Appl Biomed. 2009, 7:1533.Google Scholar
  25. 25.
    Horowitz M, Wilner AW: Impact of Event Scale: A measure of subjective stress. Psychosomatic Medicine. 1979, 41:209218.PubMedGoogle Scholar
  26. 26.
    Rudnicki SR, Graham JL, Habboushe DF, Ross RD: Social support and avoidant coping: Correlates of depressed mood during pregnancy in minority women. Women & Health. 2001, 34:1934.Google Scholar
  27. 27.
    Carver C: You want to measure coping, but your protocol’s too long: Consider the Brief COPE. International Journal of Behavioral Medicine. 1997, 4:92100.PubMedGoogle Scholar
  28. 28.
    Bellizzi K, Blank T: Predicting posttraumatic growth in breast cancer survivors. Health Psychology. 2006, 25:4756.PubMedGoogle Scholar
  29. 29.
    Tamura Y, Matsuda M, Chiba S: [Actigraphy in sleep medicine and sleep research]. Nippon Rinsho. 2009, 67:15761580.PubMedGoogle Scholar
  30. 30.
    Aardex: MEMS IV. Union City, CA, 2001.Google Scholar
  31. 31.
    Salimetrics I. State College, PA.Google Scholar
  32. 32.
    Kraemer H, Giese-Davis J, Yutsis M, et al.: Design decisions to optimize reliability of daytime cortisol slopes in an older population. American Journal of Geriatric Psychiatry. 2006, 14:325333.PubMedGoogle Scholar
  33. 33.
    Koopman C, Nouriani B, Erickson V, et al.: Sleep disturbances in women with metastatic breast cancer. Breast Journal. 2002, 8:362370.PubMedGoogle Scholar
  34. 34.
    Jacobsen P, Widows M, Hann D, et al.: Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosomatic Medicine. 1998, 60:366371.PubMedGoogle Scholar
  35. 35.
    Mormont MC, Waterhouse J: Contribution of the rest–activity circadian rhythm to quality of life in cancer patients. Chronobiol Int. 2002, 19:313323.PubMedGoogle Scholar
  36. 36.
    Bower JE: Behavioral symptoms in patients with breast cancer and survivors. Journal of Clinical Oncology. 2008, 26:768777.PubMedGoogle Scholar
  37. 37.
    Miller AH, Ancoli-Israel S, Bower J, Capuron L, Irwin MR: Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology. 2008, 26:971982.PubMedGoogle Scholar
  38. 38.
    Pati A, Parganiha A, Kar A, et al.: Alterations of the characteristics of the circadian rest–activity rhythm of cancer in-patients. Chronobiol. Int. J. Biol. Med. Rhythm Res. 2007, 24:11791197.Google Scholar
  39. 39.
    Levin R, Daehler M, Grutsch J, et al.: Circadian function in patients with advanced non-small-cell lung cancer. Br. J. Cancer. 2005, 93:12021208.PubMedGoogle Scholar
  40. 40.
    Du-Quiton J, Wood P, Burch J, et al.: Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psycho-Oncology. 2009, 18.Google Scholar
  41. 41.
    Palesh O, Zeitzer JM, Conrad A, et al.: Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. J Clin Sleep Med. 2008, 4:441449.PubMedGoogle Scholar
  42. 42.
    Archer S, Viola A, Kyriakopoulou V, von Schantz M, Dijk D: Inter-individual differences in habitual sleep timing and entrained phase of endogenous circadian rhythms of BMAL1, PER2 and PER3 mRNA in human leukocytes. Sleep. 2008, 31:608617.PubMedGoogle Scholar
  43. 43.
    Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L: The cortisol awakening response: More than a measure of HPA axis function. Neurosci Biobehav Rev. 2009.Google Scholar
  44. 44.
    Mezick E, Matthews K, Hall M, et al.: Influence of Race and Socioeconomic Status on Sleep: Pittsburgh SleepSCORE Project. Psychosomatic Medicine. 2008, 70:410416.PubMedGoogle Scholar
  45. 45.
    Gerend M, Manacy P: Social determinants of black-white disparities in breast cancer mortality: A review. Cancer Epidemiol Biomarkers Prev 2008, 17:29132923.PubMedGoogle Scholar
  46. 46.
    Giese-Davis, J., Sephton, S. E., Abercrombie, H., Duran, R. E. F., & Spiegel, D. (2004). Repression and high anxiety are associated with aberrant diurnal cortisol rhythms in women with metastatic breast cancer. Health Psychology, 23(6), 645–650.PubMedGoogle Scholar
  47. 47.
    King A, Ahn D, Atienza A, Kraemer H: Exploring refinements in targeted behavioral medicine intervention to advance public health. Annals of Behavioral Medicine. 2008, 35:251260.PubMedGoogle Scholar
  48. 48.
    Antoni M, Lutgendorf S, Cole S, et al.: The influence of bio-behavioural factors on tumour biology: Pathways and mechanisms. Nature reviews Cancer. 2006, 6:240248.PubMedGoogle Scholar
  49. 49.
    Vandewalle B, Revillion F, Lefebvre J: Functional b-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol. 1990, 116:303306.PubMedGoogle Scholar
  50. 50.
    Sood A, Bhatty R, Kamat A, et al.: Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006, 12:369375.PubMedGoogle Scholar
  51. 51.
    Sundin, E.C. and Horowitz, M.J. Impact of Event Scale: Psychometric properties. The British Journal of Psychiatry. 180:205–209 (2002).PubMedGoogle Scholar
  52. 52.
    Yusoff, N., Low, W.Y., and Yip, C.H. Reliability and validity of the Brief COPE Scale (English Version) among women with breast cancer undergoing treatment for adjuvant chemotherapy: A Malaysian Study. Medical Journal of Malaysia 65(1): 41–44 (2010).PubMedGoogle Scholar
  53. 53.
    Schwarzer, R., and Schwarzer, C. A critical survey of coping instruments. In M. Zeidner and N. S. Endler (Eds.). Handbook of Coping (1996) New York: Wiley.Google Scholar

Copyright information

© The Society of Behavioral Medicine 2012

Authors and Affiliations

  • Eric Dedert
    • 1
    • 2
  • Elizabeth Lush
    • 3
  • Anees Chagpar
    • 4
  • Firdaus S. Dhabhar
    • 5
    • 6
  • Suzanne C. Segerstrom
    • 7
  • David Spiegel
    • 5
  • Ehab Dayyat
    • 8
  • Meagan Daup
    • 3
  • Kelly McMasters
    • 9
    • 10
  • Sandra E. Sephton
    • 3
    • 10
  1. 1.Veterans Affairs Medical CenterDurhamUSA
  2. 2.Department of Psychiatry and Behavioral SciencesDuke University Medical CenterDurhamUSA
  3. 3.Department of Psychological and Brain SciencesUniversity of LouisvilleLouisvilleUSA
  4. 4.Department of SurgeryYale University School of MedicineNew HavenUSA
  5. 5.Department of Psychiatry and Behavioral SciencesStanford University School of MedicineStanfordUSA
  6. 6.Institute for Immunity, Transplantation, and InfectionStanford University School of MedicineStanfordUSA
  7. 7.Department of PsychologyUniversity of KentuckyLexingtonUSA
  8. 8.Department of PediatricsUniversity of LouisvilleLouisvilleUSA
  9. 9.Division of Surgical Oncology, School of MedicineUniversity of LouisvilleLouisvilleUSA
  10. 10.James Graham Brown Cancer CenterLouisvilleUSA

Personalised recommendations